Ph 2 clinical-stage pharma developing a new class of #NLRP3 therapeutics to treat & prevent a broad spectrum of acute & chronic inflammatory diseases

ID: 803979013437919232

linkhttp://www.olatec.com calendar_today30-11-2016 15:08:28